Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer’s disease brain

Shuko Takeda(Massachusetts General Hospital), Susanne Wegmann(Massachusetts General Hospital), Hansang Cho(University of North Carolina at Charlotte), Sarah L. DeVos(Massachusetts General Hospital), Caitlin Commins(Massachusetts General Hospital), Allyson D. Roe(Massachusetts General Hospital), Samantha B. Nicholls(Massachusetts General Hospital), George A. Carlson(McLaughlin Research Institute), Rose Pitstick(McLaughlin Research Institute), Chloe K. Nobuhara(Massachusetts General Hospital), Isabel Costantino(Massachusetts General Hospital), Matthew P. Frosch(Massachusetts General Hospital), Daniel J. Müller(Board of the Swiss Federal Institutes of Technology), Daniel Irimia(Harvard University), Bradley T. Hyman(Massachusetts General Hospital)
Nature Communications
October 13, 2015
Cited by 374Open Access
Full Text

Abstract

Tau pathology is known to spread in a hierarchical pattern in Alzheimer's disease (AD) brain during disease progression, likely by trans-synaptic tau transfer between neurons. However, the tau species involved in inter-neuron propagation remains unclear. To identify tau species responsible for propagation, we examined uptake and propagation properties of different tau species derived from postmortem cortical extracts and brain interstitial fluid of tau-transgenic mice, as well as human AD cortices. Here we show that PBS-soluble phosphorylated high-molecular-weight (HMW) tau, though very low in abundance, is taken up, axonally transported, and passed on to synaptically connected neurons. Our findings suggest that a rare species of soluble phosphorylated HMW tau is the endogenous form of tau involved in propagation and could be a target for therapeutic intervention and biomarker development.


Related Papers

No related papers found

Powered by citation graph analysis